Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 3.67% vs 2.78% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 7.54% vs 25.56% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 5.46% vs 28.63% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is -20.00% vs -16.67% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

324.92

34.03

290.89

854.80%

Other Operating Income

0.00

Total Operating income

324.92

34.03

290.89

854.80%

Raw Material Cost

78.13

16.80

61.33

365.06%

Purchase of Finished goods

10.64

0.00

10.64

(Increase) / Decrease In Stocks

-20.37

-1.26

-19.11

-1,516.67%

Employee Cost

53.88

9.46

44.42

469.56%

Power Cost

0.00

Manufacturing Expenses

0.00

0.04

-0.04

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

82.37

11.63

70.74

608.25%

Total Expenditure (Excl Depreciation)

204.65

36.67

167.98

458.09%

Operating Profit (PBDIT) excl Other Income

120.27

-2.64

122.91

4,655.68%

Other Income

4.95

11.75

-6.80

-57.87%

Operating Profit (PBDIT)

125.22

9.11

116.11

1,274.53%

Interest

0.12

0.83

-0.71

-85.54%

Exceptional Items

0.00

-1.70

1.70

100.00%

Gross Profit (PBDT)

125.10

6.58

118.52

1,801.22%

Depreciation

6.08

2.24

3.84

171.43%

Profit Before Tax

119.02

4.34

114.68

2,642.40%

Tax

30.48

1.26

29.22

2,319.05%

Provisions and contingencies

0.00

Profit After Tax

88.54

3.08

85.46

2,774.68%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

88.54

3.08

85.46

2,774.68%

Equity Capital

16.60

50.33

-33.73

-67.02%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

53.34

0.12

53.22

44,350.00%

Diluted Earnings per share

53.34

0.12

53.22

44,350.00%

Operating Profit Margin (Excl OI)

37.02%

-7.76%

0.00

44.78%

Gross Profit Margin

38.50%

19.34%

0.00

19.16%

PAT Margin

27.25%

9.05%

0.00

18.20%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 324.92 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -4.08% vs 8.92% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 3.67% vs 2.78% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 88.54 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 33.79% vs 8.17% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 7.54% vs 25.56% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 120.27 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 33.13% vs 11.64% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 5.46% vs 28.63% in Sep 2024

Quarterly - Interest

Interest 0.12 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -7.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -20.00% vs -16.67% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 37.02%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024